Trade OPKO Health, Inc. - OPK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0162 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.3969 |
| Open | 1.4269 |
| 1-Year Change | -20.57% |
| Day's Range | 1.3869 - 1.4669 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 1.4069 | 0.0100 | 0.72% | 1.3969 | 1.4269 | 1.3869 |
| Jul 24, 2024 | 1.4069 | 0.0000 | 0.00% | 1.4069 | 1.4369 | 1.3969 |
| Jul 23, 2024 | 1.4269 | 0.0000 | 0.00% | 1.4269 | 1.4569 | 1.4169 |
| Jul 22, 2024 | 1.4469 | -0.0500 | -3.34% | 1.4969 | 1.5169 | 1.4369 |
| Jul 19, 2024 | 1.4869 | -0.0100 | -0.67% | 1.4969 | 1.5369 | 1.4569 |
| Jul 18, 2024 | 1.5069 | 0.0000 | 0.00% | 1.5069 | 1.5469 | 1.4469 |
| Jul 17, 2024 | 1.4169 | 0.0000 | 0.00% | 1.4169 | 1.4269 | 1.3769 |
| Jul 16, 2024 | 1.4169 | -0.0100 | -0.70% | 1.4269 | 1.4569 | 1.4169 |
| Jul 15, 2024 | 1.4169 | 0.0400 | 2.91% | 1.3769 | 1.4569 | 1.3769 |
| Jul 12, 2024 | 1.3669 | 0.0000 | 0.00% | 1.3669 | 1.3869 | 1.3469 |
| Jul 11, 2024 | 1.3669 | 0.0200 | 1.48% | 1.3469 | 1.4069 | 1.3169 |
| Jul 10, 2024 | 1.3069 | 0.0300 | 2.35% | 1.2769 | 1.3069 | 1.2769 |
| Jul 9, 2024 | 1.2869 | -0.0100 | -0.77% | 1.2969 | 1.2969 | 1.2669 |
| Jul 8, 2024 | 1.2869 | 0.0200 | 1.58% | 1.2669 | 1.2969 | 1.2569 |
| Jul 5, 2024 | 1.2469 | 0.0400 | 3.31% | 1.2069 | 1.2469 | 1.1869 |
| Jul 3, 2024 | 1.2069 | 0.0100 | 0.84% | 1.1969 | 1.2269 | 1.1969 |
| Jul 2, 2024 | 1.2069 | -0.0200 | -1.63% | 1.2269 | 1.2269 | 1.2069 |
| Jul 1, 2024 | 1.2169 | -0.0100 | -0.82% | 1.2269 | 1.2469 | 1.2169 |
| Jun 28, 2024 | 1.2369 | -0.0200 | -1.59% | 1.2569 | 1.2769 | 1.2069 |
| Jun 27, 2024 | 1.2469 | -0.0100 | -0.80% | 1.2569 | 1.2769 | 1.2269 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
OPKO Health, Inc. Company profile
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company''s Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women''s health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units, as well as 4Kscore prostate cancer testing services. The company''s Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. It also specialty active pharmaceutical ingredients; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.| Industry: | Medical & Diagnostic Laboratories |
4400 Biscayne Blvd.
MIAMI
FLORIDA 33137
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com